In this free webinar, learn about a unique platform for
serological testing that streamlines validated analytical assays
with faster, more reliable results. Attendees will be introduced to
the VaxArray Platform and its key advantages over traditional
approaches, including sample processing in as little as 30 minutes
with real-world data collection. The featured speaker will also
discuss the benefits of developing and testing custom and
pre-validated kits with specific project examples.
TORONTO, June 26,
2024 /PRNewswire-PRWeb/ -- Serological testing plays
a pivotal role in understanding pre-existing immunity, infection
and immunogenicity. However, conventional characterization
assays often pose challenges in terms of complexity, time
consumption and resource requirements, particularly when assessing
antibody titers against multiple targets.
They will also focus on off-the-shelf kits
tailored for COVID serological testing and serological applications
for pneumococcal conjugate vaccines, in addition to a review of
corresponding data.
InDevR's VaxArray® Platform addresses these logistical hurdles
by simplifying and streamlining analytical development through its
innovative, multiplexed microarray-based technology. This
technology enables the generation of multiple results from a single
test for high-value applicability to multivalent vaccines.
The VaxArray Platform comprises a versatile range of
applications in serology and vaccine analytics, encompassing serum
antibody quantification, identity testing, antigen quantification,
characterization of nucleic acid vaccine constructs and assessment
of cell-based potency assays for mRNA vaccines. InDevR's
off-the-shelf, multiplexed kits, alongside user-friendly
instrumentation and data analysis tools, facilitate rapid sample
processing with a typical turnaround time of less than 90
minutes.
In this webinar, the expert speaker will showcase the utility of
the VaxArray Platform in serological testing, emphasizing its
distinctive advantages in this field compared to traditional
approaches. They will also focus on off-the-shelf kits tailored for
COVID serological testing and serological applications for
pneumococcal conjugate vaccines, in addition to a review of
corresponding data. Additionally, the speaker will discuss about
custom kit development for serological testing, including specific
examples of custom serology projects.
Register for this webinar today to gain insights into the
transformative capabilities of an innovative, multiplexed
microarray-based technology for serological testing and vaccine
analytics.
Join April Ruka, PhD, Application
Scientist, InDevR, for the live webinar on Tuesday, July 16, 2024, at 11am EDT (4pm
BST/UK).
For more information, or to register for this event, visit
Streamline Serological Testing Using Multiplexed Assays that
Generate Multiple Results in a Single Test.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading
provider of educational webinars and digital content to the global
life science, food, healthcare and medical device communities.
Every year, thousands of industry practitioners (from
pharmaceutical, biotechnology, food, healthcare and medical device
companies, private & academic research institutions, healthcare
centers, etc.) turn to Xtalks for access to quality content. Xtalks
helps professionals stay current with industry developments,
regulations and jobs. Xtalks webinars also provide perspectives on
key issues from top industry thought leaders and service
providers.
To learn more about Xtalks visit https://xtalks.com
For information about hosting a webinar visit
https://xtalks.com/why-host-a-webinar/
Media Contact
Soumya Shashikumar, Xtalks, +1
(416) 977-6555 x371, skumar@xtalks.com, https://xtalks.com
View original content to download
multimedia:https://www.prweb.com/releases/streamline-serological-testing-using-multiplexed-assays-that-generate-multiple-results-in-a-single-test-upcoming-webinar-hosted-by-xtalks-302182863.html
SOURCE Xtalks